To access any content or REGISTER in less than 3 minutes.
PROGRESS Reducing Recurrent Stroke Risk After Stroke or TIA

PROGRESS Reducing Recurrent Stroke Risk After Stroke or TIA

The PROGRESS trial showed that a perindopril-based BP-lowering regimen reduced recurrent stroke by 28% and major vascular events by 26% in patients with prior stroke or TIA.

Content exclusive for connected users. Please sign in or register to access more.

Already have an account?

New here?

Create account